Abridge, an AI healthcare company, has partnered with the New England Journal of Medicine (NEJM) and the JAMA Network to enhance its clinical decision support capabilities. This collaboration will integrate content from these respected journals into Abridge’s AI system, allowing clinicians to access evidence-based research during patient care. The update, which builds upon existing partnerships, aims to streamline the retrieval of medical information at the point of care. This enhancement is expected to roll out in the coming months, further promoting the use of AI tools in healthcare. Abridge currently serves over 250 health systems in the U.S. and emphasizes maintaining clinician control over final medical decisions.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.digitalhealthnews.com/abridge-partners-with-nejm-jama-network-to-expand-ai-clinical-decision-support
